Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen.Lancet Infect Dis. 2023 04; 23(4):403-404.LI
Links
Pub Type(s)
Letter
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
36803917
Citation
Huang, Junyuan, et al. "Infection Rate in Guangzhou After Easing the zero-COVID Policy: Seroprevalence Results to ORF8 Antigen." The Lancet. Infectious Diseases, vol. 23, no. 4, 2023, pp. 403-404.
Huang J, Zhao S, Chong KC, et al. Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen. Lancet Infect Dis. 2023;23(4):403-404.
Huang, J., Zhao, S., Chong, K. C., Zhou, Y., Lu, W., Fang, F., Cheung, P. P. H., Lai, K. C., Hui, D. S., & Mok, C. K. P. (2023). Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen. The Lancet. Infectious Diseases, 23(4), 403-404. https://doi.org/10.1016/S1473-3099(23)00112-3
Huang J, et al. Infection Rate in Guangzhou After Easing the zero-COVID Policy: Seroprevalence Results to ORF8 Antigen. Lancet Infect Dis. 2023;23(4):403-404. PubMed PMID: 36803917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen.
AU - Huang,Junyuan,
AU - Zhao,Shi,
AU - Chong,Ka Chun,
AU - Zhou,Yingchun,
AU - Lu,Weiguo,
AU - Fang,Fang,
AU - Cheung,Peter Pak Hang,
AU - Lai,Kiu Cheung,
AU - Hui,David Sc,
AU - Mok,Chris Ka Pun,
Y1 - 2023/02/17/
PY - 2023/01/27/received
PY - 2023/02/04/revised
PY - 2023/02/06/accepted
PY - 2023/3/28/medline
PY - 2023/2/22/pubmed
PY - 2023/2/21/entrez
SP - 403
EP - 404
JF - The Lancet. Infectious diseases
JO - Lancet Infect Dis
VL - 23
IS - 4
SN - 1474-4457
UR - https://www.unboundmedicine.com/medline/citation/36803917/Infection_rate_in_Guangzhou_after_easing_the_zero_COVID_policy:_seroprevalence_results_to_ORF8_antigen_
DB - PRIME
DP - Unbound Medicine
ER -